One of the most important aspects of this play is that Oncolix has been able to secure funding from private and/or institutional investors, long before they ever decided to go public.
They do not need to just start diluting the stock out of the gate to continue operations.
I haven't seen that being discussed here.
There are no preferred shares issued or at outstanding with super voting or convertible rights that usually burn investors.